XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended
Jan. 01, 2022
Jan. 01, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Stock options outstanding     1,357,466    
Stock options outstanding weighted average exercise price     $ 7.39    
Stock options. intrinsic value     $ 0    
Number of options granted, shares        
Employees [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share based compensation expense     $ 1,713 $ 48,828  
Unamortized stock option expense     6,853    
Non-Employees [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share based compensation expense     164,994 $ 166,518  
Unamortized stock option expense     $ 1,169,113    
Share-Based Payment Arrangement, Option [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Stock options outstanding     1,357,466   1,357,466
Stock options outstanding weighted average exercise price     $ 7.39   $ 7.39
Number of options granted, shares     (0) 50,000  
Options, exercise price per share     $ 4.84    
Share based compensation expense     $ 166,707 $ 215,346  
Unamortized stock option expense     $ 1,175,966    
Weighted average period for unamortized stock compensation (in years)     3 years 7 months 9 days    
Share-Based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share based compensation expense     $ 51,526 176,949  
Share-Based Payment Arrangement, Option [Member] | Research and Development Expense [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share based compensation expense     $ 115,181 38,397  
2016 Plan [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of additional shares granted 184,260 142,457      
Number of shares available for grant     1,543,872   1,543,872
Common Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Rounding of shares related to a reverse stock split     9,644    
Warrant [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Share based compensation expense     $ 0 $ 20,433  
Warrant shares, outstanding     1,055,066   1,537,158
Warrant exercise price     $ 17.82    
Class of warrant or right, outstanding, intrinsic value     $ 0